Bone Density Loss: Tenofovir has been affiliated with a lessen in bone mineral density, rising the risk of bone problems or fractures.In phase three clinical trials, tenofovir offered an identical efficacy than efavirenz in remedy-naive HIV people. In hepatitis B infected people, soon after 1 calendar year of tenofovir remedy, the viral DNA levels